Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Mtubatuba, KwaZulu-Natal, South Africa.
AIDS. 2010 Feb 20;24(4):593-602. doi: 10.1097/QAD.0b013e328335cff5.
We present early life mortality rates in a largely rural population with high antenatal HIV prevalence, and investigate temporal and spatial associations with a prevention of mother-to-child transmission (PMTCT) programme, an HIV treatment programme, and maternal HIV.
A retrospective cohort analysis.
All births from January 2000 to January 2007 to women in the Africa Centre demographic surveillance were included. Under-two child mortality rates (U2MR) computed as deaths per 1000 live-births per year; factors associated with mortality risk assessed with Weibull regression. Availability of PMTCT (single-dose nevirapine; sdNVP) and antiretroviral therapy (ART) in a programme included in multivariable analysis.
Eight hundred and forty-eight (6.2%) of 13 583 children under 2 years died. Deaths in under-twos declined by 49% between 2001 and 2006, from 86.3 to 44.1 deaths per thousand live-births. Mortality was independently associated with birth season (adjusted hazard ratio 1.16, 95% confidence interval 1.02-1.33), maternal education (1.21, 1.02-1.43), maternal HIV (4.34, 3.11-6.04) and ART availability (0.46, 0.33-0.65). Children born at home (unlikely to have received sdNVP) had a 35% higher risk of dying than children born in a facility where sdNVP was available (1.35, 1.04-1.74). For 2005 births the availability of PMTCT and ART in public health programmes would have explained 8 and 31% of the decline in U2MR since 2000.
These findings confirm the importance of maternal survival, and highlight the importance of the PMTCT and especially maternal HIV treatment with direct benefits of improved survival of their young children.
我们报告了在一个高产前 HIV 流行率的以农村为主的人群中的早期死亡率,并研究了与预防母婴传播(PMTCT)计划、艾滋病毒治疗计划和母婴 HIV 之间的时空关联。
回顾性队列分析。
纳入 2000 年 1 月至 2007 年 1 月期间在非洲中心人口监测点分娩的所有妇女所生的 2 岁以下儿童。每 1000 例活产中每年的死亡人数计算为婴幼儿死亡率(U2MR);使用 Weibull 回归评估与死亡率风险相关的因素。将预防母婴传播(单剂量奈韦拉平;sdNVP)和抗逆转录病毒治疗(ART)计划纳入多变量分析。
848 名(6.2%)2 岁以下儿童死亡。2001 年至 2006 年,2 岁以下儿童死亡人数下降了 49%,从每千例活产 86.3 例降至 44.1 例。死亡率与出生季节(调整后的危险比 1.16,95%置信区间 1.02-1.33)、母亲教育程度(1.21,1.02-1.43)、母亲 HIV(4.34,3.11-6.04)和 ART 供应(0.46,0.33-0.65)独立相关。在家中分娩(不太可能接受 sdNVP)的儿童死亡风险比在设施中分娩且可获得 sdNVP 的儿童高 35%(1.35,1.04-1.74)。对于 2005 年出生的儿童,如果公共卫生计划中提供 PMTCT 和 ART,自 2000 年以来 U2MR 的下降将解释 8%和 31%。
这些发现证实了产妇生存的重要性,并强调了 PMTCT 和特别是母婴 HIV 治疗的重要性,因为这直接有助于改善其幼儿的生存。